Pre-hypertension Clinical Trial
Official title:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
This study is 12 months long and consists of 5 visits at baseline, months 1, 3, 6, and 12. To determine eligibility potential subjects will have resting blood pressures (BP) measured on 2 occasions. Pre-hypertensive individuals will be invited to participate in the study. After informed consent is obtained, subjects will complete baseline visit consisting of a survey, resting BP, wear activity watch for 7 days ambulatory blood pressure monitor for 24-hours, collect saliva and urine samples. Subjects will then be randomly assigned to Tension Tamer (TT) or lifestyle education program delivered via smartphone (SPCTL) groups. At the remaining 4 visits subjects will again complete a survey, resting BP, wear activity watch for 7 days ambulatory blood pressure monitor for 24-hours, collect saliva and urine samples. Throughout the 12 months TT group will meditate twice daily and SPCTL group will log physical activity.
80 stage 1 or 2 pre-hypertensive adults, will be randomly assigned to 2x daily TT at
scheduled decreasing doses or enhanced standard of care lifestyle education program delivered
via smartphone (SPCTL) for 12 months. Subjects will participate in 5 study visits at
baseline/enrollment, 1, 3, 6 , and 12 months
TT subjects will be given the TT app. The app provides instructions on breathing awareness
meditation (BAM): focusing upon the moment by sustaining one's attention upon diaphragm
movements and related sensations while breathing in a slow, deep, relaxed manner. One learns
to passively observe thoughts, images and extraneous sounds without making judgments about
them. BAM doesn't involve analysis of historical or recent stressful experiences, but instead
centers upon learning to stay in the present moment while meditating. The app will also
collect heart rate (HR) values during each session using the phone's camera. The duration of
the TT sessions will begin at 15 min., decrease to 10 min., and finally decrease to 5 min.
Adherence will be monitored by the receipt of date-stamped heart rate values collected during
each meditation session.
SPCTL subjects will be provided Runkeeper app and taught how to record physical activity they
perform. Recommended dosage of using SPCTL media and/or app will be that of the TT group.
Adherence to SPCTL will be assessed using server file analyses of modules used and activity
recorded in Runkeeper.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03313284 -
Respiratory Muscle Training and Intermittent Hypoxia: Additive Health Effects?
|
N/A | |
Completed |
NCT01741779 -
Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function
|
N/A | |
Withdrawn |
NCT01074918 -
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
|
Phase 1/Phase 2 | |
Completed |
NCT00288158 -
Primary Prevention of Hypertension in Obese Adolescents
|
Phase 2 | |
Completed |
NCT01190319 -
Study: Effects of Strawberries on Blood Pressure
|
N/A | |
Completed |
NCT01008176 -
Restoring Sleep Homeostasis to Lower Blood Pressure
|
N/A | |
Unknown status |
NCT02197910 -
Different Dosages of Bioactive Wheat Peptides and Blood Pressure Level and CVD Risk Biomarkers in Healthy Subjects
|
N/A | |
Recruiting |
NCT04543656 -
Personalized Blood Pressure Care Using IoMTs and Artificial Intelligence
|
N/A | |
Completed |
NCT00553969 -
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00170937 -
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
|
Phase 4 | |
Completed |
NCT01741766 -
The Effects of Stretching Training on Arterial Function and Autonomic Control
|
N/A | |
Completed |
NCT02143817 -
Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition
|
N/A | |
Terminated |
NCT00388388 -
Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
|
Phase 2 | |
Completed |
NCT02148458 -
Short Term Intermittent Fasting and Mediterranean Diet
|
N/A | |
Terminated |
NCT01349114 -
Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects
|
Phase 4 | |
Completed |
NCT02038179 -
Center of Research Translation (CORT) Project 2
|
Phase 2/Phase 3 | |
Completed |
NCT00970931 -
Hypertension Prevention in Pre-Hypertensive Individuals
|
Phase 3 | |
Completed |
NCT01202175 -
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension
|
Phase 4 | |
Completed |
NCT01841840 -
The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke
|
N/A | |
Not yet recruiting |
NCT01364675 -
Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects
|
N/A |